Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-limonene is a naturally occurring monoterpene found primarily in the essential oils of citrus fruits. It has been extensively investigated for its chemopreventive and therapeutic potential across various conditions, including pancreatic and lung cancers, where it acts by inhibiting cell proliferation and inducing apoptosis, often through the inhibition of protein isoprenylation (specifically Ras proteins). Beyond oncology, d-limonene is being evaluated for the prevention and treatment of radiation-induced xerostomia (dry mouth) due to its protective effects on salivary gland function. It also serves as a non-invasive diagnostic biomarker in breath analysis for liver diseases such as metabolic dysfunction-associated steatotic liver disease (MASLD), where its exhaled concentration reflects hepatic metabolic capacity. Additionally, it is utilized in oral care formulations for its extrinsic tooth stain-removing properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on d-limonene.